Puig Domingo, Manuel <br/><br/>
Treatment of acromegaly in the era of personalized and predictive medicine.  [electronic resource] 

 -  Clinical endocrinology  Jul 2015 
 - 3-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1365-2265 
<br/><br/><label>Standard No.: </label>10.1111/cen.12731  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoma--genetics<br/>Algorithms<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Arrestins--metabolism<br/>Cadherins--metabolism<br/>Growth Hormone-Secreting Pituitary Adenoma--genetics<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--metabolism<br/>Ki-67 Antigen--metabolism<br/>Mutation<br/>Neurosurgical Procedures<br/>Octreotide--therapeutic use<br/>Peptides, Cyclic--therapeutic use<br/>Precision Medicine<br/>Prognosis<br/>Receptors, G-Protein-Coupled--genetics<br/>Receptors, Somatostatin--metabolism<br/>Somatostatin--analogs & derivatives<br/>Treatment Failure<br/>Treatment Outcome<br/>Tumor Burden<br/>beta-Arrestin 1<br/>beta-Arrestins<br/>raf Kinases--metabolism